Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Data Collection for Subjects in MDX-010 Studies
- Status
- COMPLETED
- Phase
- N/A
Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Novel Treatment for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
- Status
- TERMINATED
- Phase
- N/A
Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Intratumoral Injection Of Alpha-Gal Glycosphingolipids
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Sutent to Treat Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2